NEW YORK (GenomeWeb News) – Sunnyvale, Calif.-based Arrayit is opening a business based in Houston that will serve as a commercial arm for diagnostics that will run on the company's microarray platform.
The Arrayit Diagnostics subsidiary will promote and market tests using the microarray platform that are aimed at early-stage diagnostics. Arrayit currently is developing diagnostic tests for cancer, neurodegenerative disease, and other diseases.
The company said that Arrayit Diagnostics will launch an "intensive" marketing campaign supported by a network of 41 international life science and diagnostic distributors in 38 countries.